Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Potassium Prediction Using Machine Learning and Single-lead ECG

NCT07493798 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07493798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07493798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Potassium Prediction Using Machine Learning and Single-lead ECG
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Withdrawn
Start date
March 20, 2021
Completion date
December 1, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants; increased, asthma, atrial fibrillation rapid, chronic kidney diseases, chronic obstructive pulmonary disease, gout flare, heart failure, hypertensive urgency, infection